Certain Form of Tomatoes Could be Key to Prostate Cancer Prevention

Columbia, molybdenum - infoZine- New malignant neoplastic disease research from the University of Show Me State proposes that eating a certain word form of tomato merchandise could be the cardinal to unlocking the prostate gland cancer-fighting potentiality of the tomato. The positive consequence of tomato merchandises have been suggested in many studies, but, until now, research workers did not cognize exactly what caused this effect. "It looks that the top protective consequence from tomatoes come ups from rehydrating tomato pulverization into tomato paste," said Valeri Mossine, research helper professor of biochemistry in the College of Agriculture, Food and Natural Resources. "Processing of many comestible works through heating, grinding, mixing or drying dramatically increases their nutritionary value and cancer-fighting potential." Mossine and his co-workers establish that FruHis - an organic saccharide nowadays in dehydrated tomato merchandises - exerts a strong protective consequence against prostate gland cancer. Rats, injected with prostate gland cancer-causing chemicals, were divided into groupings and Federal different diets. The grouping Federal a diet of tomato paste plus further FruHis demonstrated the longer endurance rate. Only 10 percentage in that grouping had developed prostate gland tumors. Sixty percentage in the control grouping had tumors; 30 percentage of the grouping Federal tomato pulverization had tumors; and 25 percentage of the grouping Federal tomato paste alone had prostate gland tumors. "Before this study, research workers attributed the protective consequence of tomatoes to ascorbic acid, carotenoids or phenolic resin compounds. FruHis may stand for a novel type of possible dietary antioxidant," Mossine said. "Our in progress research now focuses on unraveling the chemical mechanisms behind why this have a good effect. This cognition may take to other avenues of research and drug development for prostate gland and other cancers. Results of this survey certainly justify clinical trials." The survey will be published in the June issue of Cancer Research, a diary of the American Association for Cancer Research. The research was funded by The Prostate Gland Cancer Foundation and the mu Agribusiness Experiment Station Chemistry Lab.